← Back to Inovio Pharmaceuticals

Revision of Inovio Pharmaceuticals

← Back to history

AB · · mediawikibotAB-V1

Rendered

Inovio Pharmaceuticals formerly known as Electrofect founded in 1999 renamed to Inovio in October 2001 is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development (June 2020). from Wikipedia

American biotechnology company

Wikitext diff vs parent

{{DISPLAYTITLE:Inovio Pharmaceuticals}}
Inovio Pharmaceuticals formerly known as Electrofect founded in 1999 renamed to Inovio in October 2001 is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development (June 2020).<small> from [https://en.wikipedia.org/wiki/Inovio_Pharmaceuticals Wikipedia]</small>

{{SF|
{{Twt|InovioPharma}}
{{Wb|http://www.inovio.com/|inovio.com}}
}}
{{IDF|
{{Wd|Q30283331}}
{{Isni|000000040417098X}}
}}

{{VHID|13766047536}}{{#subtitle: <big>American biotechnology company</big>}}